All In Biotech

Drug Trial Radar · NCT03417687

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection

Evaluation of Hyperpolarized 129Xe MRI as Compared to 133Xe Scintigraphy for the Assessment of Pulmonary Function in Patients Being Evaluated for Possible Lung Resection Surgery

Last checked: Nov 19, 2026Latest source record: Jun 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

38

Actual

Start

Aug 17, 2018

Primary completion

Oct 31, 2019

Study completion Mar 10, 2020

Sponsor

Lead sponsor
Polarean, Inc.Industry
Sponsor type
Industry
First posted
Jan 31, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study compares the equivalence of hyperpolarized 129Xe MRI as compared to 133Xe scintigraphy for the evaluation of pulmonary function in patients being evaluated for lung resection.

Conditions

  • Pulmonary Surgical Procedures

Interventions

  • 129Xe MRIDrug

    Evaluation of pulmonary function

  • 133 Xe scintigraphyDrug

    Evaluation of pulmonary function

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Predicted Percentage of Remaining Pulmonary FunctionTime frame: 48 hours

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Duke University Hospital

    Durham, North Carolina

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • University of Virginia

    Charlottesville, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.